A Comprehensive Evaluation of the Non-Motor Symptoms, Quality of Life and Caregiver Burden in Patients with Idiopathic Dystonia
Objective: To study various non-motor symptoms in idiopathic dystonia patients using validated scales. Background: Dystonia is a hyperkinetic movement disorder. There has been a recent…A 24-year-old female with 18p deletion syndrome presenting with rapidly worsening dystonia
Objective: To describe a case of rapidly worsening dystonia in 18p deletion syndrome. Background: 18p deletion syndrome resulting from deletion of the short arm of…Misdiagnosing Movement Disorders on a Terciary Academic Center in the Caribbean: A Series of Cases
Objective: To report 10 movement disorder cases misdiagnosed by general neurologists as another disorder or a different category of movement disorder. Background: The misdiagnosis of…Dystonia and Impact on Employment in a Spanish Cohort
Objective: To evaluate the effect of age at diagnosis, impact on social and family life, and complications of dystonia (such as inability to communicate correctly…Recrudescence of a Compensated Hemidystonia-hemiatrophy Syndrome After COVID-19 Infection
Objective: To educate readers about a unique presentation of hemidystonia-hemiatrophy syndrome which presented after an infection with COVID-19 Background: Hemidystonia-hemiatrophy syndrome is a rare disorder…Movement Disorders in Autoimmune Encephalitis: A case series of 11 cases.
Objective: Describe abnormal movements associated with autoimmune encephalopathies (AIE) Background: Movement disorders are a hallmark feature of autoimmune encephalitis (AIE), playing a pivotal role in…A Phase 2, Double-blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults with Isolated Cervical Dystonia
Objective: To evaluate the safety and the efficacy of ABP-450 (prabotulinumtoxinA) in patients with cervical dystonia (CD). Background: ABP-450 (prabotulinumtoxinA) is a new 900kDA botulinumtoxinA.…Stop signal reaction time: A promising Diagnostic marker for Functional Cervical Dystonia
Objective: In the current study we explored the clinical utility of Stop Signal Reaction Time (SSRT) as a diagnostic marker for functional cervical dystonia (FCD).…Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia
Objective: To assess the therapeutic outcomes of botulinum toxin injections (BoNT) in patients with lower limb dystonia (LLD). Background: BoNT to the affected muscle groups…A Comparison of Cervical Dystonia in Parkinson’s Disease and Idiopathic Isolated Cervical Dystonia
Objective: To perform a prospective analysis of the prevalence and clinical characteristics of cervical dystonia in Parkinson’s disease (CD-PD) and compare these features to those…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 48
- Next Page »